Fig. 5
From: miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
The correlation between miR-181b expression and survival time in NSCLC. Kaplan–Meier analysis of the OS (a) and DFS (b) of patients with NSCLC for whom both OS and DFS information was available in lung cancer data set from TCGA. The patients were stratified by high (greater than the median, n = 168) versus low (greater than or equal to the median, n = 161) expression of miR-181b. c, d Kaplan–Meier analysis of the correlation between miR-181b level and the OS (c) and DFS (d) of patients with NSCLC in TCGA cohort, which was further analysed for 271 NSCLC patients in stages I–II and 58 patients in stages III–IV